Midatech Pharma PLC (MTP): Price and Financial Metrics


Midatech Pharma PLC (MTP): $0.80

0.04 (+5.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MTP to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

MTP Stock Summary

  • MTP has a higher market value than only 0.24% of US stocks; more precisely, its current market capitalization is $2,757,816.
  • With a year-over-year growth in debt of -82.1%, MIDATECH PHARMA PLC's debt growth rate surpasses just 2.31% of about US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for MTP comes in at -319.71% -- higher than that of just 1.72% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to MIDATECH PHARMA PLC are SINT, MNDO, BYSI, AEZS, and PALT.
  • Visit MTP's SEC page to see the company's official filings. To visit the company's web site, go to www.midatechpharma.com.

MTP Stock Price Chart Interactive Chart >

Price chart for MTP

MTP Price/Volume Stats

Current price $0.80 52-week high $5.30
Prev. close $0.76 52-week low $0.60
Day low $0.67 Volume 75,996
Day high $0.80 Avg. volume 67,782
50-day MA $1.03 Dividend yield N/A
200-day MA $2.43 Market Cap 3.48M

Midatech Pharma PLC (MTP) Company Bio


Midatech Pharma PLC focuses on the development and commercialization of multiple, high-value, targeted therapies for major diseases with high unmet medical need in the nanomedicine field.


MTP Latest News Stream


Event/Time News Detail
Loading, please wait...

MTP Latest Social Stream


Loading social stream, please wait...

View Full MTP Social Stream

Latest MTP News From Around the Web

Below are the latest news stories about MIDATECH PHARMA PLC that investors may wish to consider to help them evaluate MTP as an investment opportunity.

Midatech Pharma PLC Announces Result of General Meeting

Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that at its General Meeting held at 10.00 a.m. today all ordinary resolutions were carried, but all other resolutions were not passed by shareholders, as set out in the table below.

Yahoo | January 23, 2023

Midatech Pharma PLC Announces Planned Dose Escalation in MTX-110 Phase 1 Study

Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce that following completion of one month of treatment with MTX-110 in the first patient, its Phase I study of MTX-110 in recurrent glioblastoma ("rGB") (NCT 05324501) will continue with a planned dose escalation following a positive recommendation from the study's Data Safety Monitoring

Yahoo | January 12, 2023

Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders

NEW HAVEN, Conn., Jan. 11, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factor and a differentiated, proprietary xB3 ™ platform for delivering therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, today announced that

Yahoo | January 11, 2023

Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting

Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines, announces, further to the Company's announcements of 13 December and 19 December 2022, that a circular (the "Circular") and Notice of General Meeting was posted to shareholders yesterday.

Yahoo | January 6, 2023

BIOAF: Merger with Midatech Pharma

By John Vandermosten, CFA OTC:BIOAF READ THE FULL BIOAF RESEARCH REPORT Bioasis Acquisition by Midatech Pharma plc. On December 13 th , 2022, Bioasis Technologies Inc. (OTC:BIOAF) announced that it will merge with Midatech Pharma plc (NASDAQ:MTP). Midatech is a drug delivery technology company with three platforms and eight programs advancing six different compounds. Its lead candidate, MTX110,

Yahoo | January 3, 2023

Read More 'MTP' Stories Here

MTP Price Returns

1-mo -15.78%
3-mo -51.52%
6-mo -78.38%
1-year -84.16%
3-year -95.73%
5-year -99.68%
YTD -18.78%
2022 -81.24%
2021 -43.85%
2020 -45.74%
2019 -55.53%
2018 -81.55%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6676 seconds.